Rutishauser U, Sachs L
Proc Natl Acad Sci U S A. 1974 Jun;71(6):2456-60. doi: 10.1073/pnas.71.6.2456.
The cell-cell binding induced by concanavalin A between single cells has been analyzed by use of cells attached to nylon fibers. Binding of a concanavalin A-coated cell to an untreated cell was found to a high degree between two lymphoma tumor cells, less frequently between a lymphoma cell and a normal lymphocyte, and only rarely between two normal lymphocytes. The binding was inhibited by the presence of a saccharide inhibitor of concanavalin A, but could not be reversed by addition of the inhibitor after the cells had bound to each other. Although no binding was obtained when both cells were coated with lectin or fixed with glutaraldehyde, fixation of a cell before coating with concanavalin A enhanced its ability to bind an untreated cell. The results indicate that cell-cell binding induced by concanavalin A requires short-range lateral movement of cell receptors for the lectin, that only one cell has to have mobile receptors, and that some receptors must be unoccupied by lectin molecules before cell-cell contact. Clustering of the receptors is not necessary and seems to hinder cell-cell binding. It is suggested that the short-range movement is required for alignment of individual receptors so as to form multi-point bridges between two cells by lectin molecules. The bridging is then followed by the formation of irreversible bonds between the cells. The receptors on tumor cells appear to have a greater ability than receptors on normal cells to align themselves for cell-cell binding.
通过使用附着在尼龙纤维上的细胞,对伴刀豆球蛋白A诱导的单细胞间细胞-细胞结合进行了分析。发现伴刀豆球蛋白A包被的细胞与未处理细胞之间的结合在两个淋巴瘤肿瘤细胞之间程度较高,在淋巴瘤细胞与正常淋巴细胞之间较少见,而在两个正常淋巴细胞之间则极为罕见。这种结合受到伴刀豆球蛋白A的糖类抑制剂的抑制,但在细胞彼此结合后添加抑制剂无法使其逆转。虽然当两个细胞都用凝集素包被或用戊二醛固定时未获得结合,但在用伴刀豆球蛋白A包被之前对一个细胞进行固定可增强其与未处理细胞结合的能力。结果表明,伴刀豆球蛋白A诱导的细胞-细胞结合需要凝集素的细胞受体进行短程横向移动,只需一个细胞具有可移动的受体,并且在细胞-细胞接触之前一些受体必须未被凝集素分子占据。受体的聚集并非必要,而且似乎会阻碍细胞-细胞结合。有人提出,短程移动是为了使单个受体排列整齐,以便通过凝集素分子在两个细胞之间形成多点桥接。然后在细胞之间形成不可逆的键。肿瘤细胞上的受体在细胞-细胞结合时排列自身的能力似乎比正常细胞上的受体更强。